Article
06 Mar 2026
Federal Court Denies Class Action Certification In Generic Drug Price Fixing Case
AUTHORS CONTENT
Article
06 Mar 2026
La Cour fédérale rejette une requête en autorisation de recours collectif relative à la fixation des prix de médicaments génériques
Article
01 Jul 2025
Health Canada Must Redetermine Exemption Requests For Psilocybin (Magic Mushroom)-Assisted Psychotherapy Training
Article
29 May 2025
Alexion Awarded Injunction Against Amgen In SOLIRIS Patent Action; Court Considers Anticipation By Incorporation By Reference
Article
02 Oct 2024
JAMP Seeks To Bring Abuse Of Dominance Case Re: STELARA
Article
31 Jan 2024
U.S. FDA Authorizes Florida Plan To Import Drugs In Bulk From Canada
Article
03 Jan 2024
Obviousness Of Lilly's Tadalafil (CIALIS) Dosage Form Patent Stands
Article
30 Nov 2023
Supreme Court Of Canada Agrees To Hear Challenge To "Multi-Crown" Class Actions Under The BC Opioid Damages And Health Care Costs Recovery Act
Article
06 Mar 2023
Health Canada's Action Plan For Non-prescription Drugs
Article
05 Aug 2019
Guidance Updates
Article
14 Jun 2019
Update On PMPRB Guidelines Modernization
Article
14 Jun 2019
Infringement Based On Making/Selling Under Existing NOC For One Strength Struck From Action Under The PMNOC Regulations Triggered By NOA Based On Different Strength
Article
08 Mar 2019
Court Upholds Minister's Refusal To List ELANCO Patent Due To Filing Date
Article
05 Feb 2019
Under Reserve: Appeal From Judicial Review Quashing PMPRB Decision On Jurisdiction Over DIFFERIN
Article
05 Feb 2019
PMPRB Issues A Notice Of Hearing For Allegations Of Excessive Pricing Of PROCYSBI
Article
06 Dec 2018
Divided Success In Sandoz's Motion To Strike Monetary Remedies And Other Novel Claims In Rituximab PMNOC Actions
Article
06 Dec 2018
Ontario Court Of Appeal Allows Sanofi And Schering To Plead That Federal Court Ramipril Patent Invalidity Decision Was Flawed Due To "Promise Doctrine"
Article
01 Aug 2018
Pharmaceutical Solid Forms – Patent Office Proposes Examination Practice
Article
31 Jul 2018
First Judicial Consideration Of Vanessa's Law: Health Canada Must Disclose Requested Clinical Trial Data
Article
24 May 2018
New Regulations Governing Post-Market Oversight Over Opioids